TGA green lights cefaclor substitution

green light new law approval
An unexpected increase in demand for oral liquid preparations of cefaclor have prompted the Therapeutic Goods Administration (TGA) to issue a Serious Scarcity Substitution Instrument (SSSI) for the medication  Pharmacists are being authorised to use their professional judgment to provide an alternative strength of cefaclor oral liquid, when the prescribed medication is not available.  

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Haleon’s virtual pharmacy tech heading to banner groups
Next Vaccine services problems spotted